
March 21, 2021
Early phase study finds combination therapy effective against difficult to treat leukemia and lymphoma
Thomas Alexander, MD, MPH, and colleagues published findings from a study that found pairing venetoclax with low-dose navitoclax and chemotherapy had promising efficacy in patients with difficult to treat leukemia and lymphoma.